cyclin Y CRISPR/Cas9 KO Plasmid (m): sc-426856
- Target species: mouse
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- cyclin Y CRISPR/Cas9 Knockout (KO) Plasmid (m) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the cyclin Y genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
cyclin Y CRISPR/Cas9 KO Plasmid (m) | sc-426856 | 20 µg | $397.00 |
Overview
Mouse Ccny encodes cyclin Y, a membrane-associated cyclin that coordinates cell-cycle–linked signaling with developmental and metabolic programs. Cyclin Y has been implicated in regulating CDK activity and facilitating Wnt/β-catenin pathway modulation through control of signaling components at the plasma membrane, influencing proliferation, differentiation, and tissue homeostasis. Ccny expression and cyclin-driven signaling dynamics are studied in contexts such as stem/progenitor cell behavior, neuronal development, and tissue remodeling, where dysregulated cell-cycle control and Wnt signaling are common features. As a result, Ccny loss-of-function models are useful for dissecting cyclin-dependent checkpoint regulation, pathway crosstalk, and phenotypes relevant to cancer biology and neurodevelopmental research.
cyclin Y CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Ccny gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Ccny together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Ccny open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish cyclin Y protein expression.
This CRISPR knockout system enables efficient generation of Ccny-deficient cell models for investigation of cyclin Y signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting Ccny exon(s) critical for cyclin Y function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple Ccny genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by cyclin Y CRISPR/Cas9 KO Plasmid (m) and cyclin Y CRISPR/Cas9 KO Plasmid (m2) target distinct sites within the Ccny locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by cyclin Y HDR Plasmid (m) and cyclin Y HDR Plasmid (m2) contain a puromycin resistance cassette and an RFP reporter flanked by Ccny homology arms to support homology-directed repair at defined Ccny target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.